Clinical Trials Browser

Recruiting × sintilimab × Lymphoid × Clear all

NCT04512534 2026-04-02

Sincerely20

Phase 2 Recruiting

Lymphoma, T-Cell, Peripheral

NCT07077512 2026-01-21

Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell Lymphoma

Phase 2 Recruiting

Lymphoma, Follicular, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell